Filter
5161
Filtered Results: 5161
Text search:
clinical
diagnosis
Featured
Recommendations
532
New Publications
1164
Language
Document type
No document type
2948
Guidelines
807
Studies & Reports
755
Manuals
262
Strategic & Response Plan
137
Fact sheets
100
Training Material
78
Situation Updates
30
Resource Platforms
16
Online Courses
11
Infographics
8
Brochures
7
App
1
Videos
1
Countries / Regions
India
308
Global
186
South Africa
138
Kenya
137
Western and Central Europe
117
Ethiopia
93
Liberia
92
Nigeria
86
Tanzania
86
Uganda
86
Latin America and the Carribbean
83
Sierra Leone
77
Africa
76
Zambia
74
Rwanda
68
Malawi
61
Nepal
60
Ghana
56
Indonesia
53
Eastern Europe
52
Bangladesh
50
Ukraine
46
Namibia
42
Brazil
38
Russia
38
Zimbabwe
35
Myanmar / Burma
33
Colombia
30
Mozambique
30
Asia
30
Philippines
28
Cambodia
28
South–East Asia Region
27
East and Southern Africa
27
Congo, Democratic Republic of
26
West and Central Africa
26
Syria
24
Guinea
22
Germany
22
Lesotho
20
Middle East and North Africa
20
South Sudan
18
Eastern Europe and Central Asia
17
Botswana
17
Senegal
15
Eswatini/ Swaziland
14
Haiti
13
Argentina
13
Paraguay
12
Burkina Faso
11
Chile
10
Cameroon
10
Albania
10
USA
10
Georgia
10
Ecuador
10
Tajikistan
9
Peru
9
Western Pacific Region
9
North America
9
Pakistan
9
Venezuela
8
North Macedonia
7
China
7
Vietnam
7
Angola
7
Armenia
6
Spain
6
Thailand
5
Benin
5
Afghanistan
5
Sri Lanka
5
Central African Republic
5
Iraq
5
Madagascar
5
Estonia
4
United Kingdom
4
Bolivia
4
Bhutan
4
Timor Leste/ East Timor
3
Iran
3
Laos
3
Guinea-Bissau
3
Jamaica
3
Papua New Guinea
3
Moldova
3
Yemen
3
Somalia
3
El Salvador
2
Turkey
2
Kazakhstan
2
Canada
2
Uzbekistan
2
Burundi
2
Bulgaria
2
Ireland
2
Saudi Arabia
2
Japan
2
Portugal
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Sudan
2
Romania
2
Greece
2
Chad
2
North Korea
1
Switzerland
1
Mexico
1
Serbia
1
Australia
1
Gambia
1
Fiji
1
Singapore
1
Kyrgyzstan
1
Malaysia
1
Morocco
1
Qatar
1
Italy
1
Dominican Republic
1
Hungary
1
Jordan
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Mauritius
1
Tunisia
1
Belarus
1
Egypt
1
Slovakia
1
Poland
1
Authors & Publishers
Publication Years
Category
Countries
1792
Clinical Guidelines
618
Public Health
295
Women & Child Health
206
Key Resources
123
Capacity Building
102
Pharmacy & Technologies
87
Toolboxes
Mental Health
535
HIV
534
TB
476
COVID-19
371
NTDs
285
Rapid Response
192
NCDs
163
AMR
156
Caregiver
152
Ebola & Marburg
139
Disability
89
Pharmacy
85
Conflict
53
Planetary Health
49
Zika
49
Refugee
46
Global Health Education
31
Specific Hazards
26
Polio
25
Cholera
23
Natural Hazards
19
Health Financing Toolbox
15
Social Ethics
11
Malaria
10
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and ...
Policy Research Working Paper 6100 | Impact Evaluation Series No. 60 | This study examines the effect of performance incentives for health care providers to provide more and higher quality care in Rwanda on child health outcomes. The authors find that the incentives had a large and significant effec...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de...
In the current absence of vaccine for COVID-19, public health response target breaking the chain of infection by focusing on the mode of transmission. This paper summarizes current evidence-base around the transmission dynamics, pathogenic, and clinical features of COVID-19, to critically identify i...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Background
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.
Methods
This review is based on articles retrieved by a selective search in PubMed, as well as on r...
It summarizes guidance on how to manage – and when to refer – children and adolescents presenting with common complaints and conditions. It includes information to enable primary health care providers to coordinate the continued care of children and adolescents with long-term conditions and dise...
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate....
Module 3
Counsellors
July 2017
Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea...
This is a case-ascertained prospective investigation of all identified health care contacts working in a health care facility in which a laboratory confirmed 2019-nCoV infected patient (see 2.2 Study population) receives care. Note that this study can be done in health care facilities at all 3 level...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
n October 2019, WHO convened the first meeting of the Buruli ulcer laboratory network (BU-LABNET) in Yaoundé, Cameroon, bringing together 11 laboratories from nine countries at the Pasteur Centre of Cameroon (CPC), the network’s Coordinating Centre. The network was formally established at th...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
Over the past 50 years, dengue has spread from nine to over a hundred countries, making it the most rapidly spreading vector-borne disease. Yet, dengue continues to have a low profile among policy-makers and donors and does not receive the media attention it deserves. While there is no vaccine or cu...
The coronavirus outbreak that began in 2019 (COVID-19) threatens to reverse years of hard-won gains in preventing and treating HIV. Fragile health systems are further stressed as health workers navigate an increased client load and demands at work while also being concerned for their own health and ...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
